These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 25925206)

  • 1. The BMI1 polycomb protein represses cyclin G2-induced autophagy to support proliferation in chronic myeloid leukemia cells.
    Mourgues L; Imbert V; Nebout M; Colosetti P; Neffati Z; Lagadec P; Verhoeyen E; Peng C; Duprez E; Legros L; Rochet N; Maguer-Satta V; Nicolini FE; Mary D; Peyron JF
    Leukemia; 2015 Oct; 29(10):1993-2002. PubMed ID: 25925206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BMI1 gene expression in myeloid leukemias and its impact on prognosis.
    Saudy NS; Fawzy IM; Azmy E; Goda EF; Eneen A; Abdul Salam EM
    Blood Cells Mol Dis; 2014 Dec; 53(4):194-8. PubMed ID: 25084695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BMI1 Inhibitors Down-regulate NOTCH Signaling and Suppress Proliferation of Acute Leukemia Cells.
    Ohtaka M; Itoh M; Tohda S
    Anticancer Res; 2017 Nov; 37(11):6047-6053. PubMed ID: 29061784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BMI1 reprogrammes histone acetylation and enhances c-fos pathway via directly binding to Zmym3 in malignant myeloid progression.
    Shen H; Chen Z; Ding X; Qi X; Cen J; Wang Y; Yao L; Chen Y
    J Cell Mol Med; 2014 Jun; 18(6):1004-17. PubMed ID: 24571310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BMI1 collaborates with BCR-ABL in leukemic transformation of human CD34+ cells.
    Rizo A; Horton SJ; Olthof S; Dontje B; Ausema A; van Os R; van den Boom V; Vellenga E; de Haan G; Schuringa JJ
    Blood; 2010 Nov; 116(22):4621-30. PubMed ID: 20724541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of BMI1 induces autophagy-mediated necroptosis.
    Dey A; Mustafi SB; Saha S; Kumar Dhar Dwivedi S; Mukherjee P; Bhattacharya R
    Autophagy; 2016; 12(4):659-70. PubMed ID: 27050456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing BMI1 radiosensitizes human breast cancer cells by inducing DNA damage and autophagy.
    Griffith J; Andrade D; Mehta M; Berry W; Benbrook DM; Aravindan N; Herman TS; Ramesh R; Munshi A
    Oncol Rep; 2017 Apr; 37(4):2382-2390. PubMed ID: 28260023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repurposing the Bis-Biguanide Alexidine in Combination with Tyrosine Kinase Inhibitors to Eliminate Leukemic Stem/Progenitor Cells in Chronic Myeloid Leukemia.
    Muselli F; Mourgues L; Rochet N; Nebout M; Guerci A; Verhoeyen E; Krug A; Legros L; Peyron JF; Mary D
    Cancers (Basel); 2023 Feb; 15(3):. PubMed ID: 36765952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol promotes autophagic cell death in chronic myelogenous leukemia cells via JNK-mediated p62/SQSTM1 expression and AMPK activation.
    Puissant A; Robert G; Fenouille N; Luciano F; Cassuto JP; Raynaud S; Auberger P
    Cancer Res; 2010 Feb; 70(3):1042-52. PubMed ID: 20103647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Hedgehog signaling pathway and autophagy overcomes drug resistance of BCR-ABL-positive chronic myeloid leukemia.
    Zeng X; Zhao H; Li Y; Fan J; Sun Y; Wang S; Wang Z; Song P; Ju D
    Autophagy; 2015; 11(2):355-72. PubMed ID: 25701353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hsp90 inhibitor, BIIB021, induces apoptosis and autophagy by regulating mTOR-Ulk1 pathway in imatinib-sensitive and -resistant chronic myeloid leukemia cells.
    He W; Ye X; Huang X; Lel W; You L; Wang L; Chen X; Qian W
    Int J Oncol; 2016 Apr; 48(4):1710-20. PubMed ID: 26892093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting of the BLT2 in chronic myeloid leukemia inhibits leukemia stem/progenitor cell function.
    Xiao M; Ai H; Li T; Rajoria P; Shahu P; Li X
    Biochem Biophys Res Commun; 2016 Apr; 472(4):610-6. PubMed ID: 26966074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of BCR-ABL-Y177-mediated p27kip1 phosphorylation and cytoplasmic localization in enhanced proliferation of chronic myeloid leukemia progenitors.
    Chu S; McDonald T; Bhatia R
    Leukemia; 2010 Apr; 24(4):779-87. PubMed ID: 20200561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia.
    Neviani P; Santhanam R; Oaks JJ; Eiring AM; Notari M; Blaser BW; Liu S; Trotta R; Muthusamy N; Gambacorti-Passerini C; Druker BJ; Cortes J; Marcucci G; Chen CS; Verrills NM; Roy DC; Caligiuri MA; Bloomfield CD; Byrd JC; Perrotti D
    J Clin Invest; 2007 Sep; 117(9):2408-21. PubMed ID: 17717597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The polycomb group BMI1 gene is a molecular marker for predicting prognosis of chronic myeloid leukemia.
    Mohty M; Yong AS; Szydlo RM; Apperley JF; Melo JV
    Blood; 2007 Jul; 110(1):380-3. PubMed ID: 17360938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential role of Notch signalling in CD34+ chronic myeloid leukaemia cells: cross-talk between Notch and BCR-ABL.
    Aljedai A; Buckle AM; Hiwarkar P; Syed F
    PLoS One; 2015; 10(4):e0123016. PubMed ID: 25849484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Overexpression of Shp-2 is associated with the unlimited growth and apoptosis resistance of p210 bcr-abl-mediated chronic myeloid leukemia].
    Zhu XZ; Yu YZ; Fang YM; Liang Y; Lü QH; Xu RZ
    Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(27):1903-6. PubMed ID: 16255985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bmi1 gene silencing inhibits the proliferation and invasiveness of human hepatocellular carcinoma cells and increases their sensitivity to 5-fluorouracil.
    Zhang R; Xu LB; Yue XJ; Yu XH; Wang J; Liu C
    Oncol Rep; 2013 Mar; 29(3):967-74. PubMed ID: 23242307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic Regulation of Bmi1 by Ubiquitination and Proteasomal Degradation Inhibit Bcl-2 in Acute Myeloid Leukemia.
    Kushwaha AC; Mohanbhai SJ; Sardoiwala MN; Sood A; Karmakar S; Roy Choudhury S
    ACS Appl Mater Interfaces; 2020 Jun; 12(23):25633-25644. PubMed ID: 32453568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCNG2 suppressor biological effects on thyroid cancer cell through promotion of CDK2 degradation.
    Li WJ; Liu GL; Yu F; Xiang XX; Lu YF; Xiao HZ; Shi YP
    Asian Pac J Cancer Prev; 2013; 14(10):6165-71. PubMed ID: 24289643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.